Updated:
GRAIL
Memorable branding for visionary founders. | Grail is a branding agency designed to help founders launch, scale, and evolve at speed. With an agile process...
GRAIL
Memorable branding for visionary founders. | Grail is a branding agency designed to help founders launch, scale, and evolve at speed. With an agile process tailored to the specific needs of startups, the agency provides branding, messaging, and websites that grow alongside its clients.
General information
Firm type
other
Year founded
2015
Location
Region
North America
Country
United States
City
Menlo Park
Corporate office
Menlo Park, CA, United States
Additional offices
San Diego, CA, United States · Princeton, NJ, United States · Palo Alto, CA, United States · Kenilworth, NJ, United States · Shenzhen, China
Principals
Josh Ofman
Chief Executive Officer
Sector focus
Frequently asked questions
Who runs investment decisions at GRAIL?
GRAIL is an operating company, not an investment vehicle. Strategic decisions are made by CEO Josh Ofman and the board of directors (per public record, 2024).
Is GRAIL still backed by Illumina?
No. Illumina spun out GRAIL as an independent company in June 2024, after acquiring it in 2021. Illumina no longer holds a controlling stake (per Illumina press release, June 2024).
What cancer types does Galleri detect?
The Galleri test detects a shared signal from over 50 cancer types, over 45 of which lack standard screening. It is marketed as a laboratory-developed test under CLIA (per GRAIL official communications).
How is GRAIL's AI/ML work structured?
GRAIL uses machine learning to analyze DNA methylation patterns from a single blood draw. Its algorithms classify the presence and tissue of origin for multiple cancers, refined through a clinical trial of over 40,000 participants (per GRAIL official communications).
Does GRAIL operate outside the US?
Yes. GRAIL has a lab in Shenzhen, China, and has conducted a major clinical trial with the U.K. National Health Service. Its corporate headquarters is in Menlo Park, CA (per public record).
What is the regulatory status of Galleri?
Galleri is available as a CLIA-validated laboratory-developed test. GRAIL is pursuing FDA approval via a Premarket Approval (PMA) pathway, with a pivotal study underway (per GRAIL official communications).
Does GRAIL take outside investment?
GRAIL raised over $2B in equity and debt from investors during its pre-acquisition phase. Post-spinout, it operates as a standalone company and may consider future rounds, but no current funding round is publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: